- Home
- MXCT vs AIRS Comparison
MXCT vs AIRS Comparison
Compare MXCT & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- AIRS
- Stock Information
- Founded
- MXCT 1999
- AIRS 2012
- Country
- MXCT United States
- AIRS United States
- Employees
- MXCT N/A
- AIRS N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AIRS Medical/Nursing Services
- Sector
- MXCT Health Care
- AIRS Health Care
- Exchange
- MXCT Nasdaq
- AIRS Nasdaq
- Market Cap
- MXCT 159.9M
- AIRS 166.3M
- IPO Year
- MXCT 2021
- AIRS 2021
- Fundamental
- Price
- MXCT $1.76
- AIRS $10.12
- Analyst Decision
- MXCT Buy
- AIRS Hold
- Analyst Count
- MXCT 4
- AIRS 3
- Target Price
- MXCT $7.50
- AIRS $3.75
- AVG Volume (30 Days)
- MXCT 841.1K
- AIRS 974.7K
- Earning Date
- MXCT 11-05-2025
- AIRS 11-07-2025
- Dividend Yield
- MXCT N/A
- AIRS N/A
- EPS Growth
- MXCT N/A
- AIRS N/A
- EPS
- MXCT N/A
- AIRS N/A
- Revenue
- MXCT $35,754,000.00
- AIRS $165,109,000.00
- Revenue This Year
- MXCT N/A
- AIRS N/A
- Revenue Next Year
- MXCT $14.80
- AIRS $5.14
- P/E Ratio
- MXCT N/A
- AIRS N/A
- Revenue Growth
- MXCT N/A
- AIRS N/A
- 52 Week Low
- MXCT $1.26
- AIRS $1.53
- 52 Week High
- MXCT $5.20
- AIRS $10.68
- Technical
- Relative Strength Index (RSI)
- MXCT 57.62
- AIRS 75.20
- Support Level
- MXCT $1.52
- AIRS $7.44
- Resistance Level
- MXCT $1.84
- AIRS $9.11
- Average True Range (ATR)
- MXCT 0.11
- AIRS 0.67
- MACD
- MXCT 0.02
- AIRS 0.22
- Stochastic Oscillator
- MXCT 79.22
- AIRS 82.44
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.